Related Experiment Video
Updated: Jul 7, 2026
12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Molecular mechanisms of prion pathogenesis
Adriano Aguzzi1, Christina Sigurdson, Mathias Heikenwaelder
1Institute of Neuropathology, University Hospital of Zürich, CH-8091 Zürich, Switzerland. adriano.aguzzi@usz.ch
Annual Review of Pathology
|February 1, 2008
Summary
Prion diseases involve misfolded prion protein (PrPSc) aggregation, leading to neurodegeneration. This review explores disease mechanisms, immune system roles, and prion strain diversity in these fatal conditions.
Area of Science:
- Neuroscience
- Infectious Diseases
- Molecular Biology
Background:
- Prion diseases are fatal, infectious neurodegenerative disorders affecting humans and animals.
- A key event is the misfolding and aggregation of cellular prion protein (PrPC) into pathogenic forms (PrPSc).
- Prion accumulation occurs in both the central nervous system and lymphoid organs.
Purpose of the Study:
- To discuss the molecular mechanisms underlying prion-induced neurodegeneration.
- To elucidate the involvement of the immune system in prion pathogenesis.
- To examine the characteristics of different prion strains.
Main Methods:
- Literature review and synthesis of existing research on prion diseases.
- Analysis of molecular pathways involved in prion protein misfolding and aggregation.
- Examination of immunological responses and prion tropism.
Main Results:
- Prion protein (PrP) misfolding and aggregation into amyloid structures are central to neurodegeneration.
- The cellular prion protein (PrPC) is essential for disease susceptibility.
- Prions exhibit diverse strains with varying tropisms and biochemical properties.
Conclusions:
- Understanding prion disease mechanisms is crucial for developing therapeutic strategies.
- The immune system plays a significant role in the progression of prion pathogenesis.
- Further research into prion strains may reveal insights into disease variability and transmission.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...